Abstract
Background
Different dosage protocols may be advocated by different clinicians for the same keloid lesion. The aim of this study was to determine the optimal frequency of injection of triamcinolone for the purpose of reducing the size of keloid, by monitoring volume change in lesions.
Methods
Volume of all lesions was measured, and 40 mg of triamcinolone was injected once. Lesion volume was thereafter monitored weekly for 6 weeks.
Results
Mean pretreatment volume was 6.4 ml. Following triamcinolone injection, mean lesion volume became 5.1, 3.7, 3.6, and 3.6 ml at 1, 2, 3, and 4 weeks postinjection, respectively. The mean lesion volume was 3.7 and 3.9 ml at 5 and 6 weeks postinjection. Mean lesion volume was 1.29 ml lower at 1 week than at pretreatment stage (SD ± 0.8797), 1.35 ml lower in volume at 2 weeks than 1 week (SD ± 1.0386), and 0.138 ml lower in volume at 3 weeks than 2 weeks (SD ± 0.159). Mean lesion volume was 0.0250 ml lower at 4 weeks than at 3 weeks (SD ± 0.3215), 0.1000 ml greater in volume at 5 weeks than 4 weeks (SD ± 0.1713), and 0.2000 ml greater in volume at 3 weeks than 2 weeks (SD ± 0.0418). There is a statistically significant difference between the mean volume at 1 week postinjection and that at pretreatment stage, between 2 and 1 week, and between 3 and 2 weeks (p ≤ 0.05). Reduction in volume was found to be most profound and statistically significant within the first 2 weeks postinjection.
Conclusions
This study finds that the optimal frequency of intralesional injection of triamcinolone involves a 2-week injection interval.
Level of Evidence: Level IV, therapeutic study
Similar content being viewed by others
References
Tang YW (1992) Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 45(5):371–373
Mutalik S (2005) Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 71(1):3–8
Oluwasanmi JO (1974) Keloids in the African. Clin Plast Surg 1:179–185
Jackson IT, Bhageshpur R, DiNick V, Khan A, Bhaloo S (2001) Investigation of recurrence rates of earlobe Keloids utilizing various post-operative therapeutic modalities. Eur J Plast Surg 24(2):88–95
Niessen FB, Spauwen PH, Schalkwijk J, Kon M (1999) On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104(5):1435–1458
Kauh YC, Rouda S, Mondragon G et al (1997) Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 37:586–589
Aluko-Olokun B, Olaitan AA, Ladeinde AL (2014) Sessile and pedunculated facial keloid scar: a comparison of response to intralesional triamcinolone injection. Eur J Plast Surg 37:255–258
Sclafani AP, Gordon L, Chadha M, Romo T (1996) Prevention of earlobe recurrence post-operatively: steroid versus radiation. Dermatol Surg 22(6):569–574
Finken MJ, Mul D (2010) Cushing’s syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars. Eur J Pediatr 169(9):1147–1149
Prabhu A, Sreekar H, Powar R, Uppin VM (2012) A randomized controlled trial comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc 39:19–25
Aluko-Olokun B, Olaitan AA, Aluko-Olokun OA (2015) Injection complications and change in keloid height following intralesional injection of lesions: a novel injection system compared with the traditional method. Eur J Plast Surg. doi:10.1007/s00238-015-1105-2
Shanthi FXM, Ernest K, Dhanraj P (2008) Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol 74(4):343–348
Muneuchi G, Suzuki S, Onodera Y, Ito O, Hata Y, Igawa HH (2006) Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 40:111–116
Bayat A, Arscott G, Ollier WE, Ferguson MW, McGrouther DA (2004) Description of morphology of keloids in Afro-Carribbeans Br. J Plast Surg 57(2):122–123
Acknowledgments
Dr. Akinbo Ayanmo Omolara was exceptionally helpful in carrying out this research. We also thank Dr. Oyedele Oluwadara Ini, and Dr. Dodo Sa’ad Muhammad, Dr. Agochi Kenneth Kenile, and Dr. Onyenwe Betty ijeoma for clinical assistance.
Conflict of interest
Bayo Aluko-Olokun, Ademola A. Olaitan, Akinola L. Ladeinde, Oluseun A. Aluko-Olokun, Morenike Olubunmi Alade, Oluwaseyi Ibukun-Obaro, Funmilola S. Adenaike declare they have no conflict of interest.
Patient consent
Consent for inclusion in this study and use of their photographs was given by all patients.
Ethical standards
This study has been carried out with approval from ethical committee of National Hospital Abuja in accordance with the ethical standards set forth in the 1964 Declaration of Helsinki and its later amendments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aluko-Olokun, B., Olaitan, A.A., Ladeinde, A.L. et al. Determination of the optimal frequency of injection of triamcinolone: monitoring change in volume of keloid lesions following injection of 40 mg of triamcinolone. Eur J Plast Surg 39, 119–124 (2016). https://doi.org/10.1007/s00238-015-1139-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00238-015-1139-5